8DECEMBER - 2021TECH OUTLOOKThe Future of Imaging and the Role of the Pathology Data Scientist in Drug DiscoveryBy Jason Hipp, Senior Director, Head of Pathology Data Science & Innovation, Translational, AstraZeneca [NASDAQ:AZN]The gold standard of cancer diagnosis is performed by pathologists reviewing thin slices of chemically stained (Hematoxylin & Eosin based, H&E) tumor tissues. This technique has changed very little in the past 100+ years. The quality and speed of Whole Slide Imaging (WSI) scanners have recently reached the ability to be used clinically. These scanners convert a glass digital slide into a giga-pixel image and have recently obtained FDA clearance.With the recent advancements of Artificial Intelligence (AI) algorithms, more specifically referred to as Machine Learning (ML) and Deep Learning (DL) algorithms, offer the ability to extract pixel level information from these gigapixel images that can not be otherwise observed by the visual interpretation by IN MY OPINIONIN MY OPINION
< Page 7 | Page 9 >